Keyphrases
Clostridioides Difficile
100%
Clostridium Difficile Infection
63%
Gut Model
56%
Difficile
51%
Human Gut
45%
Vancomycin
34%
Ribotype 027
27%
Metronidazole
26%
C.difficile Infection
23%
Reduced Susceptibility
21%
Cytotoxin
20%
Ribotyping
18%
Antimicrobial Activity
13%
Clindamycin
12%
Biofilm
12%
Toxin Production
12%
Antimicrobial
11%
Mexico
10%
Oritavancin
10%
SMT19969
10%
Linezolid
9%
Intestinal Epithelial Cells
9%
Chemostat
9%
Antimicrobial Susceptibility
8%
Sporulation
8%
PCR Ribotype 001
7%
Titre
7%
Fidaxomicin
7%
Growth Productions
6%
In Vitro Susceptibility
6%
Genome Stability
6%
Novel Antimicrobials
6%
Single nucleotide Variant
6%
Susceptibility Testing
5%
Relative Units
5%
Biofilm Formation
5%
Colony Forming Units
5%
Gut Microbiota
5%
RT027
5%
Escherichia Coli
5%
In Vitro Activity
5%
Resistance Development
5%
Immunology and Microbiology
Peptoclostridium difficile
93%
Minimum Inhibitory Concentration
23%
Biofilm
18%
Antimicrobial Agent
14%
Microflora
14%
Antimicrobial Activity
12%
Intestine Flora
12%
Agar
11%
Chemostat
11%
Antibiotic Sensitivity
11%
Sporogenesis
9%
Clostridium
7%
Spore Germination
7%
Viable Cell Count
7%
MIC90
7%
Infectious Agent
7%
Genomic Instability
6%
Single Nucleotide Polymorphism
5%
Gram-Negative Bacteria
5%
Cytotoxicity
5%
Ribotyping
5%